Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Prof Roberto Orecchia - Director of Radiation Department, European Institute of...

Hadron therapy ( Prof Roberto Orecchia - Director of Radiation Department, European Institute of Oncology, Milan )

Reductions in breast density predict potential benefit of tamoxifen

Dr Jack Cuzick - Head of Cancer Research UK Centre for Epidemiology...

Reductions in breast density predict potential benefit of tamoxifen ( Dr Jack Cuzick - Head of Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, London )

BIG 1-98: Letrozole vs tamoxifen

Dr Alan Coates - School of Public Health, University of Sydney

BIG 1-98: Letrozole vs tamoxifen ( Dr Alan Coates - School of Public Health, University of Sydney )

Continuing adjuvant tamoxifen leads to higher quality of life

Dr Shozo Ohsumi - Chief of Breast Oncology, NHO Shikoku Cancer Center...

Continuing adjuvant tamoxifen leads to higher quality of life ( Dr Shozo Ohsumi - Chief of Breast Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan )

New biomarker predicts anthracycline response

Dr John Bartlett - Professor of Molecular Pathology, Edinburgh University

New biomarker predicts anthracycline response ( Dr John Bartlett - Professor of Molecular Pathology, Edinburgh University )

New genetic modelling improves screening for breast cancer

Dr Kathie Dalessandri - Physician Scientist at the University of California...

New genetic modelling improves screening for breast cancer ( Dr Kathie Dalessandri - Physician Scientist at the University of California, San Francisco )

Herceptin Increases event-free survival in locally advanced HER2-postive breast...

Dr Luca Gianni - Director of Medical Oncology, National Cancer Institute, Milan

Herceptin Increases event-free survival in locally advanced HER2-postive breast cancer ( Dr Luca Gianni - Director of Medical Oncology, National Cancer Institute, Milan )

Zoledronic acid may have anti-tumour properties

Dr Robert Coleman - Professor of Medical Oncology, University of Sheffield

Zoledronic acid may have anti-tumour properties ( Dr Robert Coleman - Professor of Medical Oncology, University of Sheffield )

Hormone supplements reduce death from breast cancer

Sarah Marshall - Epidemiologist, University of California, Irvine

Hormone supplements reduce death from breast cancer ( Sarah Marshall - Epidemiologist, University of California, Irvine )

Breast cancer patients may have better option to reduce oestrogen levels

Dr Stephen Jones - Director of US Oncology Research Inc, Texas

Breast cancer patients may have better option to reduce oestrogen levels ( Dr Stephen Jones - Director of US Oncology Research Inc, Texas )

Use of written forms doubles breast cancer detection rate

Dr William Goodson - Senior Clinical Research Scientist, California Pacific...

Use of written forms doubles breast cancer detection rate ( Dr William Goodson - Senior Clinical Research Scientist, California Pacific Medical Center Research Institute )

Predictive value of HER2 and topoisomerase II alpha in early breast cancer...

Dr Angelo Di Leo - Sandro Pitigliani Medical Oncology Unit, Prato Hospital

Predictive value of HER2 and topoisomerase II alpha in early breast cancer patients treated with CMF or anthracycline-based adjuvant therapy ( Dr Angelo Di Leo - Sandro Pitigliani Medical Oncology Unit, Prato Hospital )

More from ecancer